CCVTC study materials
CCVTC study resources

The Narrowed Mitral Valve and the Fast Heart Rate

CCVTC · Put your knowledge to work in context.

All case studies

The Narrowed Mitral Valve and the Fast Heart Rate

A 58-year-old woman with a history of rheumatic fever as a child presents with progressive dyspnea on exertion and palpitations. During the echocardiogram her heart rate is 104 bpm in atrial fibrillation. The mitral valve appears thickened with restricted leaflet opening and commissural fusion. Planimetry on a single frame gives a mitral valve area of 1.2 cm². Continuous-wave Doppler through the mitral valve gives a mean gradient of 14 mmHg and a pressure half-time of 260 ms. The left atrium is dilated at 52 mm. The left ventricular ejection fraction is 55%.

1. Calculate the mitral valve area using the pressure half-time and compare it with the planimetry result. Which value do you trust, and why?

Read the worked answer

Pressure half-time area = 220 / PHT = 220 / 260 = 0.85 cm².

Planimetry = 1.2 cm².

The two values are discordant by more than 0.3 cm², which is clinically significant. In this patient, the planimetry value is more trustworthy for several reasons:

  • Pressure half-time is heart-rate dependent. At 104 bpm in atrial fibrillation, the diastolic filling period is short and the PHT is artificially shortened or altered, making the derived area unreliable. PHT is validated for heart rates roughly 60-90 bpm and in sinus rhythm.
  • Atrial fibrillation produces beat-to-beat variability in gradient and PHT; measurements should be averaged over multiple beats, and the PHT formula assumes a stable hemodynamic state.
  • Planimetry directly measures the anatomic orifice and is less flow-dependent. It should be measured in the parasternal short-axis view at the leaflet tips, ideally averaged over several frames.

The planimetry value of 1.2 cm² places the patient in the moderate range (1.0-1.5 cm²), whereas the PHT value of 0.85 cm² would suggest severe disease (<1.0 cm²). The mean gradient of 14 mmHg is elevated, but this too is heart-rate dependent - a fast rate increases the gradient independent of severity.

2. What additional measurements or maneuvers would help resolve the discrepancy?

Read the worked answer

Additional steps:

  1. Average measurements over multiple cardiac cycles (at least 5-10 beats) given atrial fibrillation, and report the mean rather than a single beat.

  2. Measure the mitral valve area by the continuity equation (proximal isovelocity surface area or continuity) as a third independent method. The continuity equation is less heart-rate dependent than PHT.

  3. Assess the Wilkins score (leaflet mobility, thickening, calcification, subvalvular involvement) to determine suitability for percutaneous balloon mitral valvuloplasty. A score ≤8 generally favors balloon valvuloplasty.

  4. Evaluate pulmonary artery systolic pressure and right heart findings, since the dilated left atrium and elevated gradient raise concern for pulmonary hypertension.

  5. Consider exercise or dobutamine stress echocardiography if symptoms and resting findings are discordant - a rise in mean gradient >15 mmHg or PASP >60 mmHg with exercise supports hemodynamic significance.

  6. Control the heart rate and reassess - rate control may lower the gradient and improve the reliability of PHT.

3. What are the management implications of the findings?

Read the worked answer

Management implications:

  • The patient has rheumatic mitral stenosis with a mean gradient of 14 mmHg - markedly elevated - and a dilated left atrium with atrial fibrillation. Even with a planimetry area of 1.2 cm² (moderate by area), the high gradient and symptoms suggest hemodynamically significant disease.
  • Rate control is essential: atrial fibrillation with a rapid ventricular response worsens gradients and symptoms. Beta-blockers or calcium channel blockers are first-line.
  • Anticoagulation should be considered for stroke prevention in atrial fibrillation (CHA₂DS₂-VASc score).
  • Percutaneous balloon mitral valvuloplasty is the preferred intervention if the valve morphology is favorable (Wilkins score ≤8) and there is no significant mitral regurgitation or left atrial thrombus. Otherwise, surgical commissurotomy or valve replacement may be needed.
  • Serial surveillance with echocardiography is warranted, and the patient should be counseled about endocarditis precautions and anticoagulation adherence.